Profil
Robert F.
Scumaci has been Chief Financial Officer and Executive Vice President of Sepracor, Inc. since May 20, 2008.
Previously, he served as an Executive Vice President-Finance and Administration of Sepracor since February 2001, Treasurer since March 1996, Senior Vice President-Finance and Administration from March 1996 to February 2001 and Vice President and Controller from March 1995 to March 1996.
Mr. Scumaci worked at the Ares-Serono Group from 1987 to 1994.
He was Vice President of Finance and Administration for the North American Operations of the Ares-Serono Group.
Mr. Scumaci held various finance and accounting positions at Revlon and Coopers & Lybrand.
Ehemalige bekannte Positionen von Robert F. Scumaci
Unternehmen | Position | Ende |
---|---|---|
Ares-Serono Group
Ares-Serono Group Pharmaceuticals: MajorHealth Technology Ares-Serono Group is a Swiss pharmaceutical company that manufactures and wholesales pharmaceutical products. The private company is based in Geneva, Switzerland. and has subsidiaries in Ecuador. | Corporate Officer/Principal | 01.01.1994 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Finanzdirektor/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Health Technology |
Ares-Serono Group
Ares-Serono Group Pharmaceuticals: MajorHealth Technology Ares-Serono Group is a Swiss pharmaceutical company that manufactures and wholesales pharmaceutical products. The private company is based in Geneva, Switzerland. and has subsidiaries in Ecuador. | Health Technology |